Loading...

Hexima Limited

HXL.AXASX
Healthcare
Biotechnology
A$0.01
A$0.00(0.00%)

Hexima Limited (HXL.AX) Stock Overview

Explore Hexima Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap2.2M
P/E Ratio-2.30
EPS (TTM)$-0.01
ROE-0.53%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.01

HXL.AX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hexima Limited (HXL.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.30 and a market capitalization of 2.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;